Iron deficiency remains the most common nutritional deficiency worldwide, with children and women of childbearing age at highest risk. During pregnancy, iron deficiency anemia is a well-established risk factor linked to adverse maternal and perinatal outcomes, including low birth weight, preterm delivery, and impaired cognitive development in infants.
Based on these premises, a study tested the efficacy of a multicomponent dietary supplement containing Ferric Sodium EDTA, Lactoferrin, Vitamin C, and Vitamin B12, administered daily from the first trimester through delivery.
Results showed that the supplement significantly reduced the severity of anemia in pregnant women compared to those treated with ferrous sulfate or liposomal iron. Researchers concluded that the supplement may be a safe, effective, and well-tolerated option for managing iron deficiency anemia in pregnancy, supporting both maternal health and favorable neonatal outcomes.